OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.360
-0.060 (-4.23%)
Jan 29, 2026, 11:10 AM EST - Market open
OS Therapies Employees
As of December 31, 2024, OS Therapies had 5 total employees, including 4 full-time and 1 part-time employees. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change
1
Growth
25.00%
Revenue / Employee
n/a
Profits / Employee
-$4,051,244
Market Cap
47.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 5 | 1 | 25.00% | 4 | 1 |
| Mar 31, 2024 | 4 | 0 | - | 3 | 1 |
| Sep 30, 2023 | 4 | 0 | - | 3 | 1 |
| Mar 31, 2023 | 4 | - | - | 3 | 1 |
| Dec 31, 2022 | 4 | - | - | 3 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 70 |
| LeonaBio | 26 |
| Q32 Bio | 26 |
| PDS Biotechnology | 24 |
| NeurAxis | 21 |
| iBio, Inc. | 20 |
| ABVC BioPharma | 19 |
| CervoMed | 15 |
OSTX News
- 13 days ago - OS Therapies Bone Cancer Trial Data Strengthens FDA Case - Benzinga
- 14 days ago - OS Therapies Announces Positive Biomarker Data from Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma - Newsfile Corp
- 15 days ago - OS Therapies Announces Filing Form S-1 of OS Animal Health Subsidiary - Newsfile Corp
- 17 days ago - OS Therapies Enters into Warrant Inducement Agreements - Newsfile Corp
- 24 days ago - OS Therapies Provides First Half 2026 Corporate Outlook - Newsfile Corp
- 6 weeks ago - OS Therapies Announces Successful Type C Meeting with US FDA Regarding Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma - Newsfile Corp
- 7 weeks ago - OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma - Newsfile Corp
- 7 weeks ago - OS Therapies Announces FDA PDUFA Waiver & EMA Grants Union Marketing Authorisation Eligibility - Newsfile Corp